G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $27,000 | 0.0% | 870 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $27,000 | +92.9% | 870 | +18.0% | 0.00% | 0.0% |
| Q1 2019 | $14,000 | 0.0% | 737 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $14,000 | -58.8% | 737 | +12.2% | 0.00% | -50.0% |
| Q3 2018 | $34,000 | +61.9% | 657 | +36.9% | 0.00% | 0.0% |
| Q2 2018 | $21,000 | +200.0% | 480 | +160.9% | 0.00% | – |
| Q1 2018 | $7,000 | – | 184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |